11 Nov 2016
(MENAFN) Hikma Pharmaceuticals Plc reduced its full-year revenue predictions for its generics business, due to slower ramp-up in the unit.Moreover, the firm bought U.S generic drugs business this year, proclaimed that its now predict full-year revenue from the business to reach USD600mn.Accordingly, it also said that it predicted full-year core operating profit from its generics unit to be hurt by a delay in approval of new products.In addition, the firm predicts full-year revenue to grow by 35 percent to almost USD2bn in constant currency.
17 Sep 2025
BBK and CrediMax launch exclusive offers for customers in collaboration with The Ritz-Carlton, Bahrain
31 Aug 2025
BBK announces an exceptional 6-month grace period financing campaign for Personal and Car Finance customers
13 Aug 2025
BBK’s BD 5,000,000 Al Hayrat scheme awards BD 680,000 to 390 Al Hayrat winners in August and September
04 Aug 2025
HM the King’s Support for Youth is an Inspirational Model for Their Empowerment Journey
28 Jul 2025
BBK discloses its financial results for the half year ended 30th June 2025
20 Jul 2025
CBB approves the transfer of the retail banking operations of HSBC Bank Middle East, Bahrain Branch to BBK
This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more